Elsayed Soliman to Calcium Channel Blockers
This is a "connection" page, showing publications Elsayed Soliman has written about Calcium Channel Blockers.
Connection Strength
0.137
-
Dewland TA, Soliman EZ, Davis BR, Magnani JW, Yamal JM, Piller LB, Haywood LJ, Alonso A, Albert CM, Marcus GM. Effect of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) on Conduction System Disease. JAMA Intern Med. 2016 08 01; 176(8):1085-92.
Score: 0.137